ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma
The International Journal of Biochemistry & Cell Biology · 2025
DOI: 10.1016/j.biocel.2025.106804 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2025. Verfasst von Qiu-Ai Shu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China; State Key Laboratory of Ho…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, GTPase-Activating Proteins, Biomarkers, Tumor, Adenocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The prognosis of pancreatic adenocarcinoma remains dismal up to now, partly owing to a lack of clinically feasible therapeutic targets. ARHGAP11A, a member of Rho GTPase-activating proteins family, has been reported as a prognostic biomarker and oncogene for multiple cancers. However, the specific effects of ARHGAP11A in pancreatic adenocarcinoma remain obscure. In this study, we explored and validated the oncogenic role of ARHGAP11A in pancreatic adenocarcinoma via thorough bioinformatics analyses of public databases and our own RNA-seq data, and in vitro experiments. We found that ARHGAP11A was significantly upregulated in pancreatic adenocarcinoma and correlated with poor clinical outcomes of pancreatic adenocarcinoma patients. Functional enrichment analyses revealed that ARHGAP11A-related genes were enriched in pathways of cell cycle and cell apoptosis. Further molecular functional experiments on ARHGAP11A knockdown pancreatic adenocarcinoma cell lines demonstrated that ARHGAP11A knockdown significantly inhibited cell proliferation, promoted cell cycle arrest in the G1/S stage, and induced cell apoptosis. In comparison, overexpression of ARHGAP11A could remarkably promote the proliferation, cell cycle progression, and apoptosis resistance of pancreatic adenocarcinoma cells. In conclusion, our study demonstrates that ARHGAP11A plays an oncogenic role in pancreatic adenocarcinoma, thus providing a novel therapeutic target and prognostic biomarker for patients with pancreatic adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National…
- Department of Gastroenterology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China.
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University…
- Division of Gastroenterology, Xi'an Central Hospital, Xi'an, Shaanxi 710003, China.
- Department of Gastroenterology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China; Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an, Shaanx…
- Department of Gastroenterology, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan 570100, China. Electronic address: liunafmmu@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shu, Q. A., Huang, X. D., Wu, J., Liang, X. R., Wang, Y. L., Yu, J. M., Wang, Z. W., Liu, N., Wang, J. H., & Xie, N. (2025). ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2025.106804
Vancouver
Shu QA, Huang XD, Wu J, Liang XR, Wang YL, Yu JM, et al. ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma. The International Journal of Biochemistry & Cell Biology. 2025. doi:10.1016/j.biocel.2025.106804
BibTeX
@article{Shu2025,
author = {Shu, Qiu-Ai and Huang, Xin-di and Wu, Jian and Liang, Xi-Ru and Wang, Ya-Lan and Yu, Jin-Min and Wang, Zi-Wei and Liu, Na and Wang, Jin-Hai and Xie, Ning},
title = {ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2025},
doi = {10.1016/j.biocel.2025.106804}
}
EUVIMED